As of March 2025 DexCom has a market cap of A$45.59 Billion. This makes DexCom the world's 714th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$45.59 B | -9.51% |
2024 | A$50.38 B | 184.62% |
2023 | A$17.70 B | -72.89% |
2022 | A$65.31 B | -9.01% |
2021 | A$71.78 B | 55.47% |
2020 | A$46.17 B | 61.34% |
2019 | A$28.61 B | 86.98% |
2018 | A$15.30 B | 139.58% |
2017 | A$6.38 B | -8.74% |
2016 | A$7.00 B | -23.78% |
2015 | A$9.18 B | 76.65% |
2014 | A$5.19 B | 80.66% |
2013 | A$2.87 B | 216.67% |
2012 | A$0.90 B | 48.27% |
2011 | A$0.61 B | -26.52% |
2010 | A$0.83 B | 101.67% |
2009 | A$0.41 B | 254.54% |
2008 | A$0.11 B | -59.64% |
2007 | A$0.28 B | -8.23% |
2006 | A$0.31 B | -38.66% |
2005 | A$0.51 B |
On Mar 24th, 2025 the market cap of DexCom was reported to be: